BridgeMD
New treatment option for Breast Cancer (Locally Advanced or Metastatic)
Official title Tumor Margin Skin Tattooing Before Neo-adjuvant Chemotherapy in Patients With Breast Cancer
ClinicalTrials.gov ID: NCT07478900
What this study is testing
- What it's testing
- Study Description This prospective cohort study evaluates the feasibility and effectiveness of pre-neoadjuvant tumor localization using skin tattooing, with or without radiopaque clips, in patients with biopsy-proven T2-T3 breast cancer and axillary lymph node metastasis. Eligible patients will undergo tumor localization in the supine position with the ipsilateral arm abducted to 90°.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75, women only
You may be able to join if
- Female patients aged 18-75 years
- Histologically confirmed Breast Cancer on biopsy
- Patients with T2 or T3 breast tumors planned for Neoadjuvant Chemotherapy
- Presence of a clinically palpable primary breast tumor suitable for localization
- Patients who are candidates for Breast-Conserving Surgery following neoadjuvant therapy
You likely can't join if
- Known allergy or hypersensitivity to tattooing materials used for tumor localization
- Early-stage Breast Cancer not requiring Neoadjuvant Chemotherapy
- Diagnosis of Inflammatory Breast Cancer
- T3 tumors in patients with small breast size or T4 breast cancer
- Patients unwilling to undergo Breast-Conserving Surgery
- Diffuse microcalcifications of the breast parenchyma on Mammography
See the full eligibility criteria
- Female patients aged 18-75 years
- Histologically confirmed Breast Cancer on biopsy
- Patients with T2 or T3 breast tumors planned for Neoadjuvant Chemotherapy
- Presence of a clinically palpable primary breast tumor suitable for localization
- Patients who are candidates for Breast-Conserving Surgery following neoadjuvant therapy
- Ability and willingness to provide written informed consent
- Known allergy or hypersensitivity to tattooing materials used for tumor localization
- Early-stage Breast Cancer not requiring Neoadjuvant Chemotherapy
- Diagnosis of Inflammatory Breast Cancer
- T3 tumors in patients with small breast size or T4 breast cancer
- Patients unwilling to undergo Breast-Conserving Surgery
- Diffuse microcalcifications of the breast parenchyma on Mammography
- Ductal Carcinoma In Situ
- Male Breast Cancer
- Multicentric or multifocal breast cancers
- Tumor location that precludes breast-conserving surgery
- Recurrent Breast Cancer
The study team makes the final eligibility decision.
Where it's taking place
- Bhubaneswar, Odisha, India
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bhubaneswar, Odisha, India. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.